Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter Study.

[1]  Y. Lotan,et al.  Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma , 2020, BJU international.

[2]  Steven L. Chang,et al.  Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy. , 2020, European urology.

[3]  A. Masson-Lecomte,et al.  European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update. , 2020, European urology.

[4]  S. Shariat,et al.  Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis , 2020, International Journal of Clinical Oncology.

[5]  J. Donovan,et al.  Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial , 2020, The Lancet.

[6]  S. Shariat,et al.  Management of bladder cancer in older patients: Position paper of a SIOG Task Force. , 2020, Journal of geriatric oncology.

[7]  V. Margulis,et al.  Efficacy of Preoperative Chemotherapy in High-Risk Upper Tract Urothelial Carcinoma (UTUC). , 2020, The Journal of urology.

[8]  M. Babjuk,et al.  Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC) , 2017, World Journal of Urology.

[9]  C. Dinney,et al.  Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy , 2016, World Journal of Urology.

[10]  Yair Lotan,et al.  Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer. , 2015, European urology.

[11]  R. Thompson,et al.  Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma , 2014, BJU international.

[12]  C. Stief,et al.  Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. , 2014, European urology.

[13]  T. Clozel,et al.  Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro‐ureterectomy , 2013, BJU international.

[14]  F. Montorsi,et al.  Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis. , 2012, European urology.

[15]  Y. Lotan,et al.  Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. , 2012, European urology.

[16]  K. Bensalah,et al.  The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. , 2012, European urology.

[17]  J. Coleman,et al.  Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle‐invasive and non‐organ confined disease in patients with upper tract urothelial carcinoma , 2012, BJU international.

[18]  Y. Lotan,et al.  Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. , 2011, European urology.

[19]  G. Sonpavde,et al.  Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  A. Vickers,et al.  Tumor markers in prostate cancer I: Blood-based markers , 2011, Acta oncologica.

[21]  S. Shariat,et al.  Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy , 2011, World Journal of Urology.

[22]  M. Stifelman,et al.  Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. , 2010, European urology.

[23]  J. Coleman,et al.  The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. , 2010, European urology.

[24]  R. Millikan,et al.  The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder , 2010, Clinical Cancer Research.

[25]  B. Lane,et al.  Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy , 2010, Cancer.

[26]  K. Bensalah,et al.  Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. , 2010, European urology.

[27]  B. Bochner,et al.  The effect of age and gender on bladder cancer: a critical review of the literature , 2010, BJU international.

[28]  F. Montorsi,et al.  Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. , 2009, European journal of cancer.

[29]  K. Bensalah,et al.  Advanced patient age is associated with inferior cancer‐specific survival after radical nephroureterectomy , 2009, BJU international.

[30]  M. Milowsky,et al.  Bladder cancer in the elderly. , 2009, Urologic oncology.

[31]  K. Bensalah,et al.  Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi‐institutional analysis of 1363 patients , 2009, BJU international.

[32]  F. Saad,et al.  Clinicians are poor raters of life‐expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer , 2007, BJU international.

[33]  Y. Lotan,et al.  Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. , 2007, European urology.

[34]  L. Repetto,et al.  Greater risks of chemotherapy toxicity in elderly patients with cancer. , 2003, The journal of supportive oncology.

[35]  T. Clozel,et al.  Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. , 2014, European urology.